The page is the record's research on the issuer — no analyst, no rating, no view. # Vor Biopharma Inc. (NASDAQ: VOR) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Vor Biopharma Inc., listed on NASDAQ under the ticker VOR, with ISIN US9290332074. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US). The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), the segment is not on the record, and the jurisdiction is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 93 filings in the twelve months to 2026-11-08, across 54 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-11-05, 3 days before the record date, and is of type regulatory_filing. The filings are 3 agm_egm, 4 corporate_news, 3 director_change, 29 directors_dealings, 9 prospectus, 39 regulatory_filing and 6 results. The exchange median is 6.0 days cadence gap, 52 filings and 5.0 days latency across 4,359 NASDAQ issuers. The sector median is 5.5 days cadence gap, 65.5 filings and 4.0 days latency across 176 issuers in 2836 Biological Products, (No Diagnostic Substances). The issuer's count of 93 filings is above the sector median of 65.5 and above the exchange median of 52. ## Auditor The auditor is not on the record (no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)). The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001817229.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/VOR (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/VOR (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/VOR · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp